Oakland, CA, United States of America

Russell M Lebovitz

USPTO Granted Patents = 5 

 

Average Co-Inventor Count = 4.8

ph-index = 2

Forward Citations = 37(Granted Patents)


Company Filing History:


Years Active: 2018-2024

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Russell M. Lebovitz

Introduction

Russell M. Lebovitz is a prominent inventor based in Oakland, California, known for his impactful work in the field of biomedical research. With a total of five patents, his innovations focus primarily on the detection of misfolded proteins, which holds significant implications for understanding various neurodegenerative diseases.

Latest Patents

Lebovitz's latest patents include groundbreaking methods for detecting soluble, misfolded α-synuclein protein in biological samples. His approach involves a pre-incubation mixture containing monomeric α-synuclein protein, buffer composition, salt, and an indicator. This mixture is incubated with specific beads, allowing for the determination of detectable misfolded α-synuclein aggregates in the sample. Additionally, he has developed methods and kits for amplifying and detecting misfolded tau protein, which are crucial for diagnosing tauopathies such as Alzheimer's Disease and Progressive Supranuclear Palsy.

Career Highlights

Throughout his career, Lebovitz has collaborated with esteemed organizations like Amprion, Inc. and the University of Texas System. His work reflects a deep commitment to advancing medical research through innovative methodologies.

Collaborations

In his journey, Lebovitz has worked alongside notable researchers, including Benedikt K. Vollrath and Mohammad Shahnawaz. These collaborations have further enriched his research, facilitating the development of effective diagnostic methods for serious neurological conditions.

Conclusion

Russell M. Lebovitz continues to be an influential figure in the realm of biotechnology, contributing significantly to our understanding of misfolded proteins. His patents not only demonstrate his innovative capabilities but also highlight the potential for future advancements in the diagnosis and treatment of neurodegenerative diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…